2023 Event Guide

At the 2nd Innate Killer Europe Summit we...

DISCOVERED trailblazing first handing learnings in NK, gamma delta T, iNKT, macrophage and neutrophil innate immune therapy development to widen the treatment paradigm in Oncology.

 

PROPELLED  your pipeline progression through up-to-date EMA vs FDA regulatory guidance

FORMED lasting connections by engaging directly with industry pioneers from European biopharma and academia striving to utilise groundbreaking R&D innovation to bring innovative innate immune therapies patients who need them the most.

View the 2023 Agenda for a Taster of the Meeting's Content!

Screenshot 2023-10-10 083511

*Having trouble downloading the brochure? Let us know and we'll email it to you instead.

''The whole Hanson Wade team was incredibly supportive. Loved the speed networking in
particular''

-Uwe Meyer, Key Account & Distribution Manager, CellGenix